Thulium Ltd.

High-Tech Company

Ceased to Operate Q4/2010

Graduated from: Rotem Ventures

TECH VERTICALS

Life Sciences, MedTech, Pharmaceuticals, Therapeutics

General Data

Sector	Biomed
Company Stage:	Seed
Established	2007
Number of Employees	3
Reg. Number:	abCDe

DESCRIPTION

Thulium Ltd. was developing a beta-gamma radiation source comprising of the isotope Thulium 170 (Tm 170) as a new radiation source for both HDR and LDR brachy-therapy.

TECHNOLOGY

Radioactivity.

Products and Phases

Product	Phase
N/A
A beta-gamma radiation source comprising of the isotope Thulium 170 (Tm 170) as a new radiation source for both HDR and LDR brachy-therapy.

	TARGET MARKETS
	Patients suffering from Cancer.

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Omer, Israel

Address	Bldg. No. 10, Industrial Park
POB	3010
City	Omer
Country	Israel
Zip	84965

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Prof. Gad Shani	Chief Scientist & Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

May. 13, 2007

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Technology Transfer Company	abCDe	BGN received equity in the company in exchange for providing technology & IP.
abC Defghij	Government Agency	abCDe
abC Defghij	Incubator	abCDe	Holds 45% of the company

Last Updated:	abCDe
IVC Number:	abCDe